|1.||Photophobia (Light Sensitivity)
|2.||Glucosephosphate Dehydrogenase Deficiency
|1.||Kohl, Susanne: 10 articles (10/2015 - 08/2002)|
|2.||Michaelides, Michel: 6 articles (01/2016 - 07/2010)|
|3.||Wissinger, Bernd: 6 articles (04/2015 - 08/2002)|
|4.||Carroll, Joseph: 5 articles (01/2016 - 11/2008)|
|5.||Gottlob, Irene: 5 articles (10/2015 - 05/2011)|
|6.||Aboshiha, Jonathan: 4 articles (01/2016 - 01/2014)|
|7.||Moore, Anthony T: 4 articles (10/2014 - 07/2010)|
|8.||Ali, Robin R: 4 articles (10/2014 - 08/2011)|
|9.||Bainbridge, James W: 4 articles (10/2014 - 08/2011)|
|10.||Baumann, Britta: 4 articles (07/2010 - 08/2002)|
|1.||Ciliary Neurotrophic Factor (CNTF)IBA
10/01/2014 - "Recently, CNTF was found to improve cone photoreceptor function in a canine CNGB3 achromatopsia model. "
07/01/2015 - "Two clinical trials are under way: one to better characterize humans with achromatopsia and another to study a ciliary neurotrophic factor (CNTF) implant as a treatment for patients with the CNGB3 mutation. "
10/01/2015 - "Intravitreal Ciliary Neurotrophic Factor Transiently Improves Cone-Mediated Function in a CNGB3-/- Mouse Model of Achromatopsia."
10/01/2015 - "We evaluated the effects of CNTF protein on the retinal function in an additional achromatopsia model, the CNGB3-/- mouse. "
10/01/2014 - "Dark-adaptation functions in molecularly confirmed achromatopsia and the implications for assessment in retinal therapy trials."
09/01/2014 - "To longitudinally characterize retinal structure and function in achromatopsia (ACHM) in preparation for clinical gene therapy trials. "
01/01/2014 - "To characterize retinal structure and function in achromatopsia (ACHM) in preparation for clinical trials of gene therapy. "
10/01/2015 - "Retinal Development in Infants and Young Children with Achromatopsia."
09/01/2015 - "Gene Augmentation Therapy Restores Retinal Function and Visual Behavior in a Sheep Model of CNGA3 Achromatopsia."
|3.||Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA
01/01/1992 - "No erythrocyte glucose-6-phosphate dehydrogenase (G6PD)-deficient person was detected among 90 male patients with congenital color blindness (CCB) diagnosed at the Ophthalmology Clinic of our Hospital. "
07/01/1990 - "[Frequency of color blindness and glucose-6-phosphate dehydrogenase enzyme deficiency in non-industrialized populations in the state of Nuevo León, México]."
01/01/1984 - "The Sardinian pedigrees yielded 13 new cases of nonrecombinants between the loci for HA and glucose-6-phosphate dehydrogenase (G6PD), as well as four nonrecombinants between HA and Deutan color blindness. "
12/15/1994 - "Initial linkage studies with color blindness (CB), glucose-6-phosphate dehydrogenase (G6PD) deficiency, and the blood coagulation factor IX (F9) have suggested that a gene for BP illness is located in the Xq27-q28 region. "
09/01/1984 - "Genetic linkage studies were conducted on five Old Order Amish bipolar pedigrees in 1979 and 1982, with 94 members tested for color blindness and typed for 42 red blood cell and related markers in 17 antigen systems. "
12/01/1979 - "The Xg blood group antigen (a genetic marker of a region of the X chromosome at a considerable distance from protan/deutan color blindness) was studied for linkage to bipolar manic-depressive illness. "
02/01/1998 - "We studied spatial patterns for 24 allele frequencies representing 15 systems (blood antigens, enzymes, serum proteins, color blindness, and cerumen) in Japan. "
01/01/1984 - "A Sardinian pedigree described in 1964 for having been found to segregate at the X-linked loci for the Xga antigen, G6PD deficiency, Protan and Deutan color blindness, with an instance of recombination between the last two loci, was re-examined with respect to four common X-linked DNA polymorphisms detected by molecular probes homologous to critical subregions of the human X chromosome. "
|5.||Ethambutol (Myambutol)FDA LinkGeneric
01/01/1991 - "Ethambutol-induced color-blindness in goldfish: a behavioral, electrophysiological and morphological study."
03/01/2004 - "After 3 weeks of three-combined anti-tuberculosis medications including ethambutol (1,200 mg/day), reduced visual acuity and color vision defects occurred. "
11/01/1996 - "Both acute application of ethambutol injected into the eye and chronic application by feeding the animals daily 25 mg ethambutol for 1 month had the same effect on wavelength discrimination in the range of 560-640 nm. This means that: (1) electrophysiological experiments, in which drug application is primarily acute, reflect the same disturbance as behavioural experiments, in which drug application is chronic; and that (2) the origin of the color vision defect must be retinal. "
|6.||Transferrin (beta 2 Transferrin)IBA
|9.||Factor IX (PTC)FDA LinkGeneric
|10.||sildenafil (Viagra)FDA Link
02/01/1982 - "Analyses of the accident experience of pilots who were monocular, did not meet vision standards, had color vision defects and no operational restrictions, or wore contact lenses have shown higher-than-expected accident experience in previous studies. "
07/01/2007 - "The use of tinted contact lenses in the management of achromatopsia."
01/01/2007 - "The use of tinted contact lenses in the management of achromatopsia."
02/01/1999 - "[Corrective therapy for color blindness with the help of colored contact lenses?]."
01/01/2007 - "Tinted spectacle or contact lenses may be useful in relieving photophobia associated with a number of cone disorders, including achromatopsia. "
|2.||Hydrophilic Contact Lenses (Hydrophilic Contact Lens)
04/01/2004 - "Twenty-three patients with achromatopsia or an acquired cone disorder with complaints of severe photophobia were fit with absorptive red soft contact lenses to alleviate photophobia and improve their ability to use their remaining vision more effectively The contact lenses immediately resolved the aversion to light, with dramatic improvement in visual function in all patients (determined by observation of the patient and by patient report). "
01/01/1999 - "Red laser pointers and color blindness."
10/01/1998 - "Laser pointers and color blindness."
05/01/1998 - "Laser pointers and color blindness."
04/10/1996 - "[The laser man on color blindness]."
03/01/1998 - "Urologists were tested with the Farnsworth Dichotomous Test for Color Blindness (D-15) and the Farnsworth-Munsell 100-Hue Test (FM-100) without (control) and with laser eye protection devices for coumarin green, alexandrite and holmium:YAG lasers. "